Propanc Biopharma PPCB
NASDAQ PPCB
$0.51 +0.01 (+2.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Return on Invested Capital [ROIC] (2012)

Updated

Propanc Biopharma (PPCB) recorded Return on Invested Capital [ROIC] of -1683.47% in fiscal Q4 2012 (quarter ended Jun 30, 2012), down 1386.05 percentage points from the prior quarter.

Analysis

Propanc Biopharma (PPCB) Return on Invested Capital [ROIC] (2012) Analysis & Trends

For FY2012 (ended Jun 30, 2012), Propanc Biopharma reported Return on Invested Capital [ROIC] of -227.31%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Propanc Biopharma 573,091.58 573,091.58 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 -1,683.47%
Mar 31, 2012 -297.42%
API Access

Propanc Biopharma Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=PPCB&period=max&api_key=YOUR_API_KEY